With Q1 Closed, Affy and Illumina Gear Up For 1M SNP Chip Launches as Paths Diverge | GenomeWeb
SNP genotyping rivals Affymetrix and Illumina last week each released their first-quarter earnings, with Illumina showing a healthy growth rate buoyed by its success in the genotyping market and Affymetrix, showing that it is still recovering from a difficult 2006, reporting that a profit last year turned into a loss this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.